These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2694814)
41. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses. Hu KF; Elvander M; Merza M; Akerblom L; Brandenburg A; Morein B Clin Exp Immunol; 1998 Aug; 113(2):235-43. PubMed ID: 9717973 [TBL] [Abstract][Full Text] [Related]
42. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. Wagner DK; Graham BS; Wright PF; Walsh EE; Kim HW; Reimer CB; Nelson DL; Chanock RM; Murphy BR J Clin Microbiol; 1986 Aug; 24(2):304-6. PubMed ID: 3755731 [TBL] [Abstract][Full Text] [Related]
43. The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice. Routledge EG; Willcocks MM; Samson AC; Morgan L; Scott R; Anderson JJ; Toms GL J Gen Virol; 1988 Feb; 69 ( Pt 2)():293-303. PubMed ID: 3339327 [TBL] [Abstract][Full Text] [Related]
52. Two distinct subtypes of human respiratory syncytial virus. Mufson MA; Orvell C; Rafnar B; Norrby E J Gen Virol; 1985 Oct; 66 ( Pt 10)():2111-24. PubMed ID: 2413163 [TBL] [Abstract][Full Text] [Related]
53. Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus. Bourgeois C; Corvaisier C; Bour JB; Kohli E; Pothier P J Gen Virol; 1991 May; 72 ( Pt 5)():1051-8. PubMed ID: 2033389 [TBL] [Abstract][Full Text] [Related]
55. Clinical and epidemiologic aspects of respiratory syncytial virus antigenic variants in Argentinian children. Salomón HE; Avila MM; Cerqueiro MC; Orvell C; Weissenbacher M J Infect Dis; 1991 May; 163(5):1167. PubMed ID: 2019767 [No Abstract] [Full Text] [Related]
56. Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice. Martinez X; Li X; Kovarik J; Klein M; Lambert PH; Siegrist CA Eur J Immunol; 1999 Oct; 29(10):3390-400. PubMed ID: 10540351 [TBL] [Abstract][Full Text] [Related]
58. T-cells in respiratory syncytial virus (RSV) infection. Askonas BA; Openshaw P; Cannon M Adv Exp Med Biol; 1989; 257():9-17. PubMed ID: 2533461 [No Abstract] [Full Text] [Related]
59. Evidence that the fusion protein of respiratory syncytial virus exists as a dimer in its native form. Brief report. Arumugham RG; Hildreth SW; Paradiso PR Arch Virol; 1989; 106(3-4):327-34. PubMed ID: 2774976 [TBL] [Abstract][Full Text] [Related]
60. Immunogenicity and pathogenicity of a triple temperature-sensitive modified respiratory syncytial virus in adult volunteers. Pringle CR; Filipiuk AH; Robinson BS; Watt PJ; Higgins P; Tyrrell DA Vaccine; 1993; 11(4):473-8. PubMed ID: 8470433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]